Do we know more about hypertension in Poland after the May Measurement Month 2017?-Europe.


Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
Apr 2019
Historique:
accepted: 15 02 2019
entrez: 3 5 2019
pubmed: 3 5 2019
medline: 3 5 2019
Statut: ppublish

Résumé

Elevated blood pressure (BP) is a worldwide burden, leading to over 10 million deaths yearly. May Measurement Month (MMM) is a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for BP screening. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017. BP measurement, the definition of hypertension and statistical analysis followed the globally approved MMM17 Study Protocol. In Poland 5834 (98.9%, Caucasian) individuals were screened. After multiple imputation, 2601 (35.3%) had hypertension. Of individuals not receiving anti-hypertensive medication, 976 (20.6%) were hypertensive. Of individuals receiving anti-hypertensive medication, 532 (49.1%) had uncontrolled BP. In the crude screened group, 81.4% declared to not receive any anti-hypertensive treatment, while the remaining 18.6% were on such medications. In overweight and obese patients both systolic and diastolic BP were significantly higher than in normal weight and underweight subjects. In addition, BP measured on Sundays was significantly lower than on Mondays. MMM17 was one of the largest recent BP screening campaigns in Poland. We found that over 1/3 of participants were hypertensive. Almost half of the treated subjects had uncontrolled BP. These results suggest that opportunistic screening can identify substantial numbers with raised BP.

Identifiants

pubmed: 31043891
doi: 10.1093/eurheartj/suz067
pii: suz067
pmc: PMC6479426
doi:

Types de publication

Journal Article

Langues

eng

Pagination

D97-D100

Références

Kardiol Pol. 2005;63(6 Suppl 4):S614-9
pubmed: 20527432
Kardiol Pol. 2013;71(4):381-92
pubmed: 23788344
J Hypertens. 2016 Mar;34(3):532-8; discussion 538
pubmed: 26771343
Pol Arch Med Wewn. 2016 Aug 18;126(9):662-671
pubmed: 27535012
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Lancet Glob Health. 2018 Jul;6(7):e736-e743
pubmed: 29778399
Arch Med Sci. 2018 Aug;14(5):951-961
pubmed: 30154875

Auteurs

Jolanta Małyszko (J)

Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, Banacha 1a, 02-097 Warszawa, Poland.

Mirosław Mastej (M)

Mastej Medical Center, Staszica 21, 38-200 Jasło, Poland.

Maciej Banach (M)

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Zeromskiego 113, 90-549 Łodz, Poland.

Andrzej Tykarski (A)

Department of Hypertension, Angiology and Internal Medicine, Poznan University of Medical Sciences, Dluga1/2, 61-848 Poznan, Poland.

Krzysztof Narkiewicz (K)

Department of Hypertension and Diabetology, Medical University of Gdansk, Debinki 7, 80-952 Gdansk, Poland.

Piotr Hoffman (P)

Department of Congenital Heart Disease, Institute of Cardiology, Alpejska 42, 04-628 Warszawa, Poland.

Piotr Jankowski (P)

I Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, 31-501 Kraków, Poland.

Michał P Nowicki (MP)

Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Pomorska 251, 92-213 Łodz, Poland.

Tomasz Tomasik (T)

Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bochenska 4, 31-061 Kraków, Poland.

Adam Windak (A)

Department of Family Medicine, Chair of Internal Medicine and Gerontology, Jagiellonian University Medical College, Bochenska 4, 31-061 Kraków, Poland.

Agnieszka Olszanecka (A)

I Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kopernika 17, 31-501 Kraków, Poland.

Agnieszka Motyl (A)

Medicover Poland, Jerozolimskie 96, 00-807 Warszawa, Poland.

Dariusz Nowak (D)

Municipal Hospital, Mickiewicza 12, 42-200 Czestochowa, Poland.

Łukasz Skowron (Ł)

Department of Gastroenterology, Endocrinology and Internal Diseases, Military Institute of Medicine, Szaserów 128, 04-141 Warszawa, Poland.

Maciej Tomaszewski (M)

Division of Cardiovascular Sciences, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.

Xin Xia (X)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.

Peter Nillson (P)

Lund University, Skane University Hospital, Malmo, Sweden.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, W12 7RH, UK.

Jacek Jóźwiak (J)

Department of Family Medicine and Public Health, Institute of Medicine, University of Opole, Oleska 48, 45-052 Opole, Poland.

Classifications MeSH